The fifth batch of national procurement implementation time determines that the new competitive landscape is approaching

Notice! The fifth batch of national procurement has been confirmed at the time of implementation

01 Determination of execution time

Recently, the Centralized Procurement Network of Medicines and Medical Consumables of Liaoning Province issued the "Notice on the Implementation of the Fifth Batch of National Organized Drug Centralized Procurement (Liaoning) to Supplement the Network of Selected Drugs, Liaoning Pharmaceutical Procurement Office [2021] No.

Liaoning Province plans to start the implementation of the fifth batch of centralized procurement by national organizations (Liaoning) at the end of October

The national organization that has been online procurement in Liaoning Province organizes drug centralized procurement (Liaoning) to supply the list of drugs after the selection, and the Provincial Public Resource Trading Center completes price adjustments according to the implementation time and implements them simultaneously; encourage other non-selected supply to Liaoning Province as a supplier The selected drug manufacturers in other countries in the cargo area directly purchase online in Liaoning Province at the selected price

Xinjiang also determined the execution time

The notice clearly stated that the fifth batch of national procurement in Xinjiang will be implemented on September 15, 2021

At the same time, the notice has the following specific schedules for the relevant work during the implementation of the fifth batch of centralized procurement:

(1) Before August 25, the government service and public resource trading center of the autonomous region organizes selected production companies, distribution companies and medical institutions to sign the "Tripartite Procurement Agreement" with a valid seal on the drug procurement management platform of Xinjiang medical institutions;

(2) The 30% advance working capital will be allocated before August 30, and the local (prefecture, municipal) medical security bureau will clarify the procurement budget based on the selected price and agreed procurement volume of the selected drugs on the basis of the total budget;

(3) Before September 10, production companies and distribution companies should transport the selected products to the warehouses of local distribution companies;

(4) Before September 15th, medical institutions shall purchase the selected products and be admitted to the hospital

02 Multi-province release notices

Although some provinces have not yet determined the implementation time, the time for the online connection has been announced one after another

Sichuan

On August 27, the Sichuan Pharmaceutical Equipment Bidding and Purchasing Service Center issued the "Chuan Yao Zhao [2021] No.

The notice clearly stated that the deadline for companies to submit their application materials online is September 3, 2021

Provisions are also made: in accordance with the "Six Provinces and Two Districts" Inter-provincial Alliance Drug Centralized Purchase Documents, "When the national drug centralized procurement results in the procurement cycle overlap with the alliance region drug centralized drug procurement results, the first year will be implemented.

The "six provinces and two districts" inter-provincial alliance drug centralized procurement of selected products lipoic acid injection (small-volume injection) and lansoprazole for injection (sterile powder for injection) are selected first in the "six provinces and two districts" As a result, after the implementation of the "six provinces and two districts" selection results in this procurement cycle, the fifth batch of national centralized procurement results will be implemented in the second year

Jilin

On August 27, the Jilin Provincial Public Resources Trading Center issued the "Notice on the Implementation of the Fifth Batch of National Organizations in Jilin Province and the Online Application of Drug Purchases in Eight Provinces and Two Districts

Drugs within the scope of application must be entered on the official website of the Jilin Provincial Public Resources Trading Center through the "drug system login" to enter the "Drug Classification Procurement System-Basic Database System" before September 1, 2021 to maintain corporate information, drug information and " The Credit Commitment Letter of the Price and Marketing Behavior of Pharmaceutical Enterprises" and submit relevant information

Recently, 14 provinces and cities have released the latest news on the fifth batch of centralized procurement, including Ningxia Hui Autonomous Region, Anhui, Jiangxi, Xinjiang, Guizhou, Shanghai, and Guangdong.

Graphics: Cyber ​​Blue

03 The first three batches of nationally sourced varieties are renewing the contract

Looking back at the first three batches of national sourcing, the “4+7” pilot program began in 2018, stipulating that centralized procurement takes 12 months from the implementation date of results as a procurement cycle; the second batch of national sourcing, the procurement cycle of selected varieties from 4 or more companies is 3 years (1 company for 1 year, 2 or 3 companies for 2 years); the third batch of national procurement, the procurement cycle gradually stabilizes, and the subsequent two batches of national procurement also maintain the procurement cycle regulations, that is: the number of selected companies is less than or equal to 2 The number of selected companies is 1 year in principle; the number of selected companies is 3, which is 2 years in principle; the number of selected companies is greater than or equal to 4, which is 3 years in principle

The estimated time found that the procurement cycle of many batches of nationally-sourced drugs has exceeded the prescribed time.
At this time, they are facing a new problem-contract renewal
.
Cyberlane found out that there are already multiple batches and varieties that have been renewed.
From the perspective of the renewal of each batch, the renewal of the bid is different in each province
.

Take "4+7" centralized procurement as an example, when the expansion will expire:

Guangdong: start the renewal report, pharmacies can still participate;

Heilongjiang: On the basis that the purchase volume in the second purchase year is not lower than the first year, the price will be determined through negotiation between the medical institution and the enterprise, and it will be implemented on December 19;

Shanxi: After soliciting opinions one by one from 11 selected companies including paroxetine hydrochloride, the contract will be renewed at the original price for one year;

Hubei: On the basis of ensuring the relative stability of enterprises, market expectations and price levels, the “inquiry before bidding” approach was adopted to carry out the contract renewal and bidding work.
After bidding, the company with the lowest price is the newly selected company
.

At present, the second batch and the third batch of products are renewed, and the national procurement has had a profound impact on the price reduction of drugs
.

04 The sixth round of national procurement, a new competitive landscape is approaching

At present, the first five batches of national sourcing have covered 218 varieties, which is closer to the "500 centralized sourcing varieties catalog" spread in the industry
.
If calculated on the basis of the national procurement schedule of two batches a year, this goal is expected to be completed by 2023
.

According to the previous five rounds and six batches of rules, the company may still be eligible for the proposed selection or still meet one of the three conditions of 1.
8 times the fuse mechanism, and 50% or more of the reduction unit comparable price is less than or equal to 0.
1 yuan
.

Every round of national procurement is a place for enterprises to contend for supremacy
.
Take the fifth batch of national procurement as an example, the number of companies involved has reached more than 200, both domestic and foreign companies have been included
.
Judging from the competitive situation of each round of national procurement, it is a new "hard battle"
.

In the fifth batch of centralized procurement, Hengrui Medicine’s two important products, iodixanol injection and glycopyrrolate injection, failed to win the bid.
Among them, the contrast agent product "iodixanol injection" has more than half of the domestic market share
.
After the news came out, the share price of Pharmaceutical Hengrui dropped more than 4% at the opening day
.

Although it is not yet possible to determine the specific impact on enterprises after the implementation of the fifth batch of national procurement, from the previous rounds of national procurement analysis, the market structure of some drugs may be re-divided, and enterprises will also usher in a new competitive landscape
.

There has been news in the industry that proprietary Chinese medicines and insulin will be purchased in large quantities.
If they enter the country, they will have a non-negligible impact on enterprises
.

Both Liaoning Province and Xinjiang have determined the implementation time of the fifth batch of national procurement.
At present, the time is basically the same as the previous CCTV news report "It is expected that patients will be able to use reduced-price drugs in October this year.
" I believe the execution time is just around the corner
.